Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis.
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Maria I
MI
Carlo
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: feldmand@mskcc.org.
Darren R
DR
Feldman
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell; D006801:Humans; D007676:Kidney Failure, Chronic; D007680:Kidney Neoplasms; D000077594:Nivolumab
D000911:Antibodies, Monoclonal; D000077594:Nivolumab